Krystal Biotech (KRYS) Raw Materials (2023 - 2026)

Krystal Biotech has reported Raw Materials for 4 years, with the latest figure at $15.3 million in Q2 2026.

• Raw Materials for Q2 2026 came in at $15.3 million, up 8.58% year-over-year; the trailing twelve-month figure through Jun 2026 was $15.3 million (up 8.58% YoY), and the FY2025 annual result was $15.9 million, up 16.86% from the prior year.
• Raw Materials climbed to $15.3 million in Q2 2026, from $15.2 million in the prior quarter.
• Over five years, Raw Materials peaked at $15.9 million in Q4 2025 and troughed at $3.2 million in Q4 2023.
• A 4-year average of $11.4 million and a median of $14.1 million in 2025 frame the typical range for Raw Materials.
• The widest annual swing landed in 2024, when Raw Materials jumped 332.44%; it then gained 0.22% in 2026.
• A 4-year view of Raw Materials shows it stood at $3.2 million in 2023, then jumped by 332.44% to $13.6 million in 2024, then advanced by 16.86% to $15.9 million in 2025, then slipped by 4.26% to $15.3 million in 2026.
• Per Business Quant data, the three most recent Raw Materials figures were $15.3 million in Q2 2026, $15.2 million in Q1 2026, and $15.9 million in Q4 2025.